Unser neuester Zugang im Portfolio ist GlaxoSmithKline, ein weltweit führender Arzneimittelhersteller, Forschungskonzern und Anbieter von Gesundheitsprodukten. Das Portfolio von GlaxoSmithKline umfasst Produkte zur Prävention und der Behandlung von akuten und chronischen Erkrankungen. 155 more words
Tags » GlaxoSmithKline
Since 1981, when UNC Hospitals admitted its first patient with AIDS, UNC has worked toward the bold goal of curing a patient with HIV.
Now UNC hopes to accelerate the discovery of a cure for AIDS by partnering with GlaxoSmithKline, a world leader in AIDS research. 544 more words
When we sat down and thought about starting our investment portfolio we had a simple objective in mind: earn enough in dividend income throughout our working lives so that we can cover our expenses during retirement from our dividends. 780 more words
UNC announced a partnership with leading pharmaceutical company GlaxoSmithKline to research and develop a cure for AIDS at a press conference on Monday.
UNC and GSK will create a new company, Qura Therapeutics, and a new center, the HIV Cure Center. 477 more words
5:01 AM BST
May 5, 2015
Incoming Chairman Of GlaxoSmithKline Plc Philip Hampton
Incoming Chairman Of GlaxoSmithKline Plc Philip Hampton, is no stranger to big challenges or high-profile roles. 1,101 more words